Pages that link to "Q41988381"
Jump to navigation
Jump to search
The following pages link to Structure-based redesign of proteins for minimal T-cell epitope content (Q41988381):
Displaying 13 items.
- Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models (Q24610025) (← links)
- Mapping the Pareto optimal design space for a functionally deimmunized biotherapeutic candidate (Q28543006) (← links)
- Removing T-cell epitopes with computational protein design. (Q30362724) (← links)
- Computationally driven deletion of broadly distributed T cell epitopes in a biotherapeutic candidate. (Q30363065) (← links)
- Protein deimmunization via structure-based design enables efficient epitope deletion at high mutational loads (Q30371474) (← links)
- Depletion of T cell epitopes in lysostaphin mitigates anti-drug antibody response and enhances antibacterial efficacy in vivo. (Q35638576) (← links)
- Toward reducing immunogenicity of enzyme replacement therapy: altering the specificity of human β-glucuronidase to compensate for α-iduronidase deficiency (Q35786392) (← links)
- EpiSweep: Computationally Driven Reengineering of Therapeutic Proteins to Reduce Immunogenicity While Maintaining Function (Q36212517) (← links)
- Computationally optimized deimmunization libraries yield highly mutated enzymes with low immunogenicity and enhanced activity (Q36399908) (← links)
- HIV-1 and its resistance to peptidic carbohydrate-binding agents (CBAs): an overview. (Q38291704) (← links)
- Design and engineering of deimmunized biotherapeutics. (Q38870681) (← links)
- A high throughput MHC II binding assay for quantitative analysis of peptide epitopes. (Q39766269) (← links)
- Engineering Stability, Viscosity, and Immunogenicity of Antibodies by Computational Design (Q92772589) (← links)